Stock Information
Madrigal Pharmaceuticals Inc (MDGL)
Ticker Symbol: MDGL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $12,474.96 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -12.87
Revenue (TTM): $44.05 M
Dividend Yield: N/A
ROE: -56.65%
Latest News
-
Novo Nordisk: Capital Markets Day Reveals Its Next Growth Engine
Thu, Sep 24, 2026 9:39 AM
-
Goldman Sachs Reinstates Buy on Madrigal Pharmaceuticals, Announces $704 Price Target
Thu, Sep 24, 2026 8:40 AM
-
Citigroup Initiates Coverage On Madrigal Pharmaceuticals with Buy Rating, Announces Price Target of $725
Wed, Sep 23, 2026 11:04 AM
-
Tracking John Paulson's Paulson & Company Portfolio: Q2 2026 Update
Tue, Sep 22, 2026 7:55 PM
Key Financials
Financial data not available
